Physician profile
William Steptoe
NPI 1518031442
$13,201.94
in general payments reported to CMS, 2019-2025
52 companies · $2,162 in 2025
The $2,162 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $847 · 2020: $1,068 · 2021: $2,413 · 2022: $2,020 · 2023: $2,082 · 2024: $2,610 · 2025: $2,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,853.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,902.89 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,460.68 | 2020-2025 | Vraylar, Qulipta, Linzess |
| Glaxosmithkline, LLC. | $1,201.85 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,059.98 | 2020-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $1,003.36 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $686.97 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $532.50 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $388.55 | 2021-2025 | |
| Daiichi Sankyo INC. | $374.55 | 2019-2025 | Injectafer |
| Amgen INC. | $358.89 | 2019-2025 | Repatha, Otezla, Evenity |
| Abbott Laboratories | $355.16 | 2020-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $315.82 | 2020-2025 | Veozah |
| Merck Sharp & Dohme LLC | $249.06 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $238.34 | 2019-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $225.80 | 2019-2021 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $225.63 | 2020-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $203.48 | 2020-2024 | |
| Exact Sciences Corporation | $203.31 | 2023-2024 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $190.52 | 2020-2024 | Yupelri |
| Novartis Pharmaceuticals Corporation | $173.83 | 2020-2023 | |
| Inogen, INC. | $173.01 | 2022-2025 | Inogen At Home Stationary Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Sumitomo Pharma America, INC. | $154.89 | 2023-2025 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $142.77 | 2025 | Caplyta |
| Amarin Pharma, INC. | $114.12 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $113.17 | 2021-2023 | Ztlido |
| Dexcom, INC. | $112.96 | 2021-2025 | Dexcom G6 Transmitter |
| Sunovion Pharmaceuticals INC. | $103.99 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $91.25 | 2020-2025 | Zoryve |
| Axsome Therapeutics, INC. | $83.21 | 2024-2025 | Auvelity, Symbravo |
| Allergan, INC. | $67.74 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $65.42 | 2023-2024 | Quviviq |
| Nestle Healthcare Nutrition INC. | $56.54 | 2021-2022 | |
| Eisai INC. | $48.17 | 2020-2021 | |
| Ardelyx, INC. | $41.97 | 2025 | Ibsrela |
| Teva Pharmaceuticals USA, INC. | $40.62 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $40.48 | 2021-2025 | Fanapt, Hetlioz |
| Almatica Pharma LLC | $39.38 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.33 | 2019-2020 | |
| Boston Scientific Corporation | $31.17 | 2025 | General - Erectile Dysfunction |
| Biohaven Pharmaceutical Holding Company LTD. | $25.98 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $25.60 | 2021 | |
| Corcept Therapeutics | $25.16 | 2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $24.58 | 2025 | Voquezna |
| Becton, Dickinson and Company | $23.23 | 2022 | |
| Xeris Pharmaceuticals, INC. | $22.94 | 2025 | Gvoke Hypopen |
| Sanofi Pasteur INC. | $22.54 | 2025 | |
| Avanir Pharmaceuticals, INC. | $21.44 | 2019 | |
| Nevro Corp. | $21.28 | 2021 | |
| Insulet Corporation | $21.23 | 2024 | Omnipod |
| Philips North America LLC | $20.89 | 2024 | (Ck7) Extended Holter |
| Esperion Therapeutics, INC. | $20.83 | 2021 | |
| Medtronic, INC. | $14.88 | 2025 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Steptoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.